Biden announces willingness to forcibly license pharma patents

But the US administration’s proposed policy for compulsory licensing is somewhat less radical than the rhetoric suggests

South Korea nears adoption of ‘K-discovery’ system for trade secrets and patents suits

But push by key industry players has forced Korean legislators to soften their proposed US-style discovery proposals

Doing more with less – managing IP rights in the downtimes

Experts shed light on the best ways to reduce IP costs without compromising, with portfolio preparation and thorough evaluation of options taking centre stage.

Long Read
Data & Tools
Featured from Insight

Unlock unlimited access to all IAM content